文献速递创伤与烧伤心脑血管急症

损伤后临时制动期间静脉血栓栓塞风险:Aberdeen VTE 风险工具评估

Venous thromboembolism risk following temporary immobilisation after injury: evaluation of the Aberdeen VTE risk tool.
PubMed 文献 · Emerg Med J · 2023-01-18
一句话结论在急诊因损伤行下肢临时制动并常规使用 Aberdeen VTE 工具的患者中,症状性 VTE 发生率低于 1%;TRiP(cast) 等序贯评分可能更准确反映风险,但需前瞻性比较。

研究为前瞻性队列服务评估,纳入 2014 年 2 月至 2020 年 12 月急诊出院前用 Aberdeen VTE 风险工具评估的 ≥16 岁下肢损伤制动患者,共 1763 例(平均年龄 46 岁,SD 18;51% 女性),随访至拆除制动后 3 个月,观察症状性 VTE 或肺栓塞猝死。15 例(0.85%,95%CI 0.52%~1.40%)发生主要终点;Aberdeen 工具识别 1053 例(59.7%)需血栓预防,敏感度 80.0%(95%CI 54.8%~93.0%),特异度 40.4%(95%CI 38.1%~42.6%)。在 1695 例中,TRiP(cast) 与 Plymouth 评分判为高危者更少(33.3%、24.4%),但特异度更高(67.0%、75.6%)。作者认为序贯 RAM 可能更准确反映 VTE 风险、便于个体化预防决策,但需前瞻性比较。

要点

  • 常规使用 Aberdeen VTE 工具的患者中,症状性 VTE 或 PE 猝死发生率 0.85%(15/1763,95%CI 0.52%~1.40%)。
  • Aberdeen 工具将 59.7%(1053/1763)患者判为需血栓预防,敏感度 80.0%(95%CI 54.8%~93.0%)、特异度 40.4%(95%CI 38.1%~42.6%)。
  • 在 1695 例中,TRiP(cast) 判为高危 33.3%、Plymouth 判为高危 24.4%,均少于 Aberdeen 工具,但特异度更高(67.0%、75.6%)。
  • 作者认为 TRiP(cast) 等序贯 RAM 可能更准确反映 VTE 风险并支持更个体化的血栓预防决策,但需前瞻性比较。

适用人群与场景

  • 成年患者(≥16 岁)因损伤接受下肢制动,且在急诊出院前用 Aberdeen VTE 风险工具完成评估者;纳入时间为 2014 年 2 月至 2020 年 12 月,随访至拆除制动后 3 个月。

诊断标准与关键阈值

  • Aberdeen VTE 风险工具:用于决定下肢制动损伤患者是否接受药物血栓预防,本研究中 59.7%(1053/1763)被识别为需血栓预防。
  • TRiP(cast) 评分(Thrombosis Risk Prediction for Patients with cast immobilisation)与 Plymouth 评分作为对照 RAM,于 1695 例中回顾性计算并比较诊断性能。

研究设计与关键结果

  • 前瞻性队列服务评估:1763 例下肢损伤制动患者,平均年龄 46 岁(SD 18),51% 女性;15 例(0.85%,95%CI 0.52%~1.40%)发生症状性 VTE 或 PE 所致猝死。
  • Aberdeen VTE 工具识别 1053 例(59.7%)需血栓预防,对主要结局敏感度 80.0%(95%CI 54.8%~93.0%)、特异度 40.4%(95%CI 38.1%~42.6%)。
  • 在 1695 例中,TRiP(cast) 判为高危者 33.3%、Plymouth 判为高危者 24.4%,均少于 Aberdeen 工具,但特异度分别为 67.0% 与 75.6%,高于包括 Aberdeen VTE 工具在内的二分类 RAM。

证据类型、等级与局限

  • 证据类型:前瞻性队列服务评估(prospective cohort service evaluation)。
  • 局限:作者指出序贯 RAM(如 TRiP(cast) 评分)需前瞻性比较(prospective comparison is needed)。

对床旁实践的改变

  • 作者认为,序贯 RAM(如 TRiP(cast) 评分)可能更准确反映 VTE 风险,并支持更个体化的血栓预防决策;但需前瞻性比较,原文未据此给出常规换用推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Temporary lower limb immobilisation following injury is a risk factor for symptomatic venous thromboembolism (VTE). Pharmacological thromboprophylaxis can mitigate this risk but it is unclear which patients benefit from this intervention. The Aberdeen VTE risk tool was developed to tailor thromboprophylaxis decisions in these patients and this evaluation aimed to describe its performance in clinical practice. Secondarily, diagnostic metrics were compared with other risk assessment methods (RAMs).

METHODS: A prospective cohort service evaluation was conducted. Adult patients (≥16 years) managed with lower limb immobilisation for injury who were evaluated with the Aberdeen VTE risk tool prior to discharge from the ED were identified contemporaneously between February 2014 and December 2020. Electronic patient records were scrutinised up to 3 months after removal of immobilisation for the development of symptomatic VTE or sudden death due to pulmonary embolism (PE). Other RAMs, including the Thrombosis Risk Prediction for Patients with cast immobilisation (TRiP(cast)) and Plymouth scores, were assimilated retrospectively and diagnostic performance compared.

RESULTS: Of 1763 patients (mean age 46 (SD 18) years, 51% women), 15 (0.85%, 95% CI 0.52% to 1.40%) suffered a symptomatic VTE or death due to PE. The Aberdeen VTE tool identified 1053 (59.7%) patients for thromboprophylaxis with a sensitivity of 80.0% (95% CI 54.8% to 93.0%) and specificity of 40.4% (95% CI 38.1% to 42.6%) for the primary outcome. In 1695 patients, fewer were identified as high risk by the TRiP(cast) (33.3%) and Plymouth (24.4%) scores, but with greater specificity, 67.0% and 75.6%, respectively, than dichotomous RAMs, including the Aberdeen VTE tool.

CONCLUSION: Routine use of the Aberdeen VTE tool in our population resulted in an incidence of symptomatic VTE of less than 1%. Ordinal RAMs, such as the TRiP(cast) score, may more accurately reflect VTE risk and permit more individually tailored thromboprophylaxis decisions but prospective comparison is needed.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Almoosawy SA, Ofosu-Asiedu A, Hanna J, et al. Venous thromboembolism risk following temporary immobilisation after injury: evaluation of the Aberdeen VTE risk tool. Emerg Med J. 2023. PMID: 36653159. doi:10.1136/emermed-2022-212723

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。